Nivolumab–relatlimab

Status:
Red
Decision Date:
February 2024
 

Comments

RED: NICE TA950 - for untreated unresectable or metastatic melanoma in people 12 years and over. NHSE commissioned. (Decision date - February/March 2024)

Red Drug Classifications

  • 8. NHS England commissioned – to be used in line with NHSE commissioning intentions

search again

Derby and Derbyshire ICB

Derby and Derbyshire ICB

Please click the button to navigate to our app

Redirect to app